Statins for polycystic ovary syndrome in varying resource settings: a phenome-wide association study and evidence synthesis. [PDF]
Zahn LA +8 more
europepmc +1 more source
<i>Citri grandis</i> Exocarpium Extract Alleviates Atherosclerosis in ApoE<sup>-/-</sup> Mice by Modulating the Expression of TGF-β1, PI3K, AKT1, PPAR-γ, LXR-α, and ABCA1. [PDF]
Xu J +5 more
europepmc +1 more source
Network pharmacology combined with experiments to explore the molecular mechanism of Jiawei Erzhi pill protects against atherosclerosis by inhibiting ferroptosis. [PDF]
Guiping MA +6 more
europepmc +1 more source
Repurposing a Lipid-Lowering Agent to Inhibit TNBC Growth Through Cell Cycle Arrest. [PDF]
Hsu YC, Lee KT, Pei SN, Rau KM, Tsai TH.
europepmc +1 more source
Protective Role of Lipid-Lowering Drugs in Breast Cancer: Effects on Cancer Incidence and Cardiotoxicity. [PDF]
Mauriello A +7 more
europepmc +1 more source
Retraction Note: Simvastatin and Atorvastatin inhibit DNA replication licensing factor MCM7 and effectively suppress RB-deficient tumors growth. [PDF]
Li J +15 more
europepmc +1 more source
Simvastatin-Mediated Molecular Mechanisms Underlying the Growth Inhibition of Testicular Leydig Tumour Cells. [PDF]
De Luca A +7 more
europepmc +1 more source
Effect of <i>Spirulina platensis</i> Versus Simvastatin on the Skeletal Muscles of Experimentally Induced Dyslipidemia: A Multitarget Approach to Muscle Ultrastructural and Cytomolecular Modulation. [PDF]
Abdelhady ME +3 more
europepmc +1 more source
Charantin targets HMGCR-PCSK9 axis and activates PPAR-α signaling to ameliorate hyperlipidemia: Mechanistic insights from bioinformatics and in-vivo studies. [PDF]
Abbas G +7 more
europepmc +1 more source
Correction for Wang et al., Interplay of mevalonate and Hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motility. [PDF]
europepmc +1 more source

